Pharvaris (PHVS) EBIT (QoQ) (2020 - 2026)
Powered by 
Analysis
Pharvaris (PHVS) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Pharvaris | 2.15 Bn | 1.78 Bn | 85,072.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.94% |
| Mar 31, 2026 | -100.00% |
| Dec 31, 2025 | 306,823,027.82% |
| Sep 30, 2025 | 9.53% |
| Jun 30, 2025 | -15.50% |
| Mar 31, 2025 | -100.00% |
| Dec 31, 2024 | 258,249,670.57% |
| Sep 30, 2024 | -30.32% |
| Jun 30, 2024 | -3.85% |
| Mar 31, 2024 | 5.01% |
| Dec 31, 2023 | -13.52% |
| Sep 30, 2023 | -20.13% |
| Jun 30, 2023 | -4.95% |
| Mar 31, 2023 | -77.30% |
| Dec 31, 2022 | 43.48% |
| Sep 30, 2022 | -114.10% |
| Jun 30, 2022 | 51.53% |
| Mar 31, 2022 | -299.27% |
| Dec 31, 2021 | 65.35% |
| Sep 30, 2021 | 14.12% |